Wikipedia -WSS

Wikipedia

author：focus 2025-09-03 15:16:55 - browse：3525

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： At ASCO, AstraZeneca reports strong data for breast cancer drug

WSS

Medicare slashes safety net hospital payments by nearly $1 billion

Ionis drug prevents swelling attacks due to hereditary angioedema

A controversial new treatment promises to make little people taller

Pharma showers House GOP doctor with campaign cash

Medicare slashes safety net hospital payments by nearly $1 billion

Personalized medicine goes far beyond genetics

entertainment

Wikipedia

hotspot

Continuity nursing helped my family in our darkest PICU moments

FDA's Pazdur wants cancer trials to range beyond China alone

Novavax promises a turnaround & Lilly roils the obesity market

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Guidelines to prevent youth baseball injuries need more muscle

2 officers injured in shooting in Orlando, police say

Virginia high school admissions case could be legal follow

Letters to First Opinion on caregivers, digital health, and more

What does generative AI mean for health care? We asked experts

Flint parents haunted by uncertainty, fears of lead poisoning

entertainment

H.R. 3 is the wrong path to lower drug costs

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

With trial win, GSK could get blood cancer drug back on market

H.R. 3 is the wrong path to lower drug costs

Pharma showers House GOP doctor with campaign cash

When waiting feels immoral: Empathy in the emergency department

leisure time

knowledge

hotspot

leisure time